You have 9 free searches left this month | for more free features.

Histiocytoma, Malignant Fibrous

Showing 51 - 75 of 4,243

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thuflep/SOLEP : Initial Experience and Results of Prostate Laser

Completed
  • Prostate Hyperplasia
    • Rouen, France
      Clinique Saint Hilaire
    Mar 8, 2022

    Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor Trial in United States (Pazopanib 400 mg QD - Gemcitabine and

    Terminated
    • Sarcoma
    • +4 more
    • Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination
    • Los Angeles, California
    • +3 more
    Dec 11, 2017

    Doppler Ultrasound and CT Versus Laparoscopy in Assessment of

    Recruiting
    • Ovarian Cancer
    • Laparoscopy
    • Mansoura, Dakahlia, Egypt
      Mansoura University Hospital
    Oct 25, 2023

    Erythropoietic Protoporphyria (EPP) Trial in United States (MT-7117 low dose, MT-7117 high dose, Placebo)

    Completed
    • Erythropoietic Protoporphyria (EPP)
    • MT-7117 low dose
    • +2 more
    • Los Angeles, California
    • +8 more
    Dec 22, 2022

    Analysis of Metabonomics for Pleural Effusion

    Completed
    • Pleural Diseases
    • Detection of pleural effusion
    • (no location specified)
    Jun 15, 2023

    Tethered Cord, Tethered Cord Syndrome, Occult Spina Bifida Trial in New York (Release of filum terminale)

    Recruiting
    • Tethered Cord
    • +3 more
    • Release of filum terminale
    • New York, New York
      Weill Cornell Medicine
    Jul 15, 2022

    Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

    Not yet recruiting
    • Pleural Effusion, Malignant
    • pleural markers
    • (no location specified)
    Jan 20, 2023

    Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • Peking, Beijing, China
      Department of radiation oncology, Peking University Third Hospit
    Jun 20, 2023

    Oral Submucous Fibrosis Trial in Karachi (Nigella sativa oil, Betamethasone Valerate)

    Completed
    • Oral Submucous Fibrosis
    • Nigella sativa oil
    • Betamethasone Valerate
    • Karachi, Sindh, Pakistan
      Ziauddin University, Clifton
    Mar 14, 2022

    Coronavirus Infection and Hematologic Diseases Trial in Russian Federation (Non-interventional study)

    Completed
    • Coronavirus Infection and Hematologic Diseases
    • Non-interventional study
    • Ekaterinburg, Russian Federation
    • +14 more
    Jan 25, 2023

    Hydronephrosis; Obstruction, Ureter, Renal Failure, Malignancy Trial in Petah Tikva, Ramat Gan (ureteral stent\s insertion)

    Not yet recruiting
    • Hydronephrosis; Obstruction, Ureter
    • +4 more
    • ureteral stent\s insertion
    • Petah Tikva, Israel
    • +1 more
    Aug 8, 2023

    Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

    Recruiting
    • Brain Gliomas
    • Allogenic B7H3 CAR-γδT cell
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Aug 25, 2023

    Malignant Tumor of Bone, Perioperative Period Trial (Tik Tok)

    Not yet recruiting
    • Malignant Tumor of Bone
    • Perioperative Period
    • Tik Tok
    • (no location specified)
    Jan 11, 2023

    PAncreatic Disease Cohort of TOuLouse

    Not yet recruiting
    • Pancreatic Diseases
      • Toulouse, France
        Rangueil hospital
      Apr 19, 2023

      Df-Life : Quality of Life in Patients With Fibrous Dysplasia

      Not yet recruiting
      • Fibrous Dysplasia
      • FD qualitative study on quality of life
      • FD quantitative sudy on quality of life and olfaction.
      • Lyon, France
        Edouard Herriot Hospital - rheumatology
      Nov 9, 2022

      Cryobiopsy of Peripheral Lymph Nodes Trial in Fort Sam Houston (Cryobiopsy, Core Needle Biopsy)

      Not yet recruiting
      • Cryobiopsy of Peripheral Lymph Nodes
      • Cryobiopsy
      • Core Needle Biopsy
      • Fort Sam Houston, Texas
        Brooke Army Medical Center
      Nov 1, 2023

      Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

      Recruiting
      • Hematopoietic Organs; Disorder
      • CD62L depleted donor lymphocyte infusion
      • Hong Kong, Hong Kong
        Hong Kong Children's Hospital
      Sep 6, 2023

      Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)

      Not yet recruiting
      • Recurrent or Metastatic Solid Tumors
      • Recombinant Anti-EpCAM-CD3 Antibody Injection
      • (no location specified)
      Oct 17, 2023

      Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

      Active, not recruiting
      • Bone Diseases
      • Pain
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 17, 2022

      Progressive Disease of Corneae Trial in Pristina (ReLex-smile)

      Enrolling by invitation
      • Progressive Disease of Corneae
      • ReLex-smile
      • Pristina, Kosovo
        Eye Hospital Pristina
      Mar 21, 2022

      Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

      Enrolling by invitation
      • Malignant Melanomas
      • Recombinant Human Adenovirus Type 5 Injection
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
      Jul 7, 2023

      Gynecological Tumor Trial in Chengdu (Aprepitant Injection)

      Not yet recruiting
      • Gynecological Tumor
      • Aprepitant Injection
      • Chengdu, Sichua, China
        Dengfeng Wang
      Aug 22, 2023

      Gastric Cancer, Tongue Images, Diagnosis Trial in Hangzhou (Tongue imaging, tougue coating, saliva, and feces)

      Recruiting
      • Gastric Cancer
      • +2 more
      • Tongue imaging, tougue coating, saliva, and feces
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Oct 5, 2023

      New Method to Differentiate Benign and Malignant Pulmonary

      Not yet recruiting
      • Pulmonary Nodules
        • (no location specified)
        Sep 21, 2023